-
Mashup Score: 0Harnessing Twitter to empower scientific engagement and communication: The ISTH 2020 virtual congress experience - 3 year(s) ago
As a result of the coronavirus disease 2019 pandemic, the International Society on Thrombosis and Haemostasis (ISTH), like many societies around the world, canceled their in‐person hematology congres…
Source: Wiley Online LibraryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
FLT180a: A New Gene Therapy Candidate for Severe Hemophilia B – Bleeding Disorders, On Location, Other Meetings – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Extended Half-Life Factor VIII Fusion Protein Effective in Previously Untreated Hemophilia A - ASH Clinical News - 4 year(s) ago
Extended Half-Life Factor VIII Fusion Protein Effective in Previously Untreated Hemophilia A – Bleeding Disorders, On Location, Other Meetings – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Late-Breaking Abstracts Address Thrombosis and COVID-19 – COVID-19 News, On Location, Other Meetings – ASH Clinical News
Source: ASH Clinical NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2
Christoph Königs (Frankfurt, Germany) presented the final results of the phase 3 PUPs A-LONG study (NCT02234323). 103 previously untreated patients (<6 years) with haemophilia A were treated with an extended half-life recombinant factor VIII Fc fusion protein. The primary endpoint was the incidence of inhibitor development. A secondary endpoint was annualised bleeding rate. 87 patients completed...
Source: The Lancet HaematologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A weekly interview-style podcast hosted by Dr. David Henry that takes developments in hematology-oncology and asks, “Now what?” …
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Blood & Cancer | MDedge - 4 year(s) ago
A weekly interview-style podcast hosted by Dr. David Henry that takes developments in hematology-oncology and asks, “Now what?” …
Source: www.mdedge.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A weekly interview-style podcast hosted by Dr. David Henry that takes developments in hematology-oncology and asks, “Now what?” …
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A weekly interview-style podcast hosted by Dr. David Henry that takes developments in hematology-oncology and asks, “Now what?” …
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Blood & Cancer | MDedge - 4 year(s) ago
A weekly interview-style podcast hosted by Dr. David Henry that takes developments in hematology-oncology and asks, “Now what?” …
Source: www.mdedge.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
'Harnessing Twitter to empower scientific engagement and communication.' This forum relays the ISTH 2020 virtual congress experience through the lens of the event's #twitter ambassadors. Check it out, it's #OpenAccess. 👉 https://t.co/torbhi9X05 @isth @RPTHjournal #ISTH2020 https://t.co/L8gQIcyjH7